Non-Invasive Intracranial Pressure Monitoring Devices Market Size

Non-Invasive Intracranial Pressure Monitoring Devices Market Analysis

The non-invasive intracranial pressure monitoring devices market is expected to register a CAGR of 3.8% over the forecast period.

The outbreak of the pandemic has impacted the market. COVID-19 has increased mortality and morbidity rates among patients suffering from neurological disorders. For instance, as per our analysis and an October 2021 study from Lancet, COVID-19 was closely associated with mental and neurological disorders. The study also reported that younger patients with mental and neurological disorders were associated with higher mortality than elders. Similarly, according to a study published by the NCBI in March 2021, COVID-19 was associated with neurological complications that impacted the central and peripheral nervous systems. Continuous intracranial pressure (ICP) monitoring is essential in neurocritical care. Therefore, the demand for non-invasive intracranial pressure monitoring devices is expected to remain high and maintain an upward trend over the forecast period.

The increasing incidence of neurological disorders and rising inclination towards minimally invasive and non-invasive procedures are also major drivers for the market. For instance, as per the Mordor Intelligence analysis and a July 2021 article from Lancet, India carries a huge burden of neurological diseases along with mental health disorders and substance abuse. Neurological diseases alone account for nearly 10.0% of all diseases in India, along with another 10.6% of the prevalence of psychiatric disorders. With more than 20.0 million people suffering from these diseases, this has emerged as a serious challenge to India's public health system. Since non-invasive intracranial pressure monitoring devices are one of the essential requirements for managing neurological disorders the demand for these is likely to grow and thus, considerable market growth is anticipated over the forecast period.

According to another study published by the NCBI in January 2021, hypertensive intracerebral hemorrhage (HICH) is the most serious complication of hypertension. Minimally invasive surgery (MIS) is widely used and plays an important role in the treatment of hypertensive intracerebral hemorrhage. Minimally invasive hematoma evacuation is a simple and quick operation and can prevent injury to brain tissues and blood vessels and reduce the risk of postoperative mortality and complications.

Furthermore, the advantages of minimally invasive procedures such as less pain, rapid recovery rate, shorter hospital stays, minimal scarring, and a lower rate of complications have largely increased their adoption rate. However, the lack of trained professionals is likely to hinder the market growth over the forecast period.